Private Companies Report - The Freedonia Group

Cosmeceuticals -
Private Companies Report
• Profiles the top private US producers and
distributors of cosmeceutical products
• Analyzes outlook for cosmeceuticals
• Reveals annual sales and employment
An essential tool if you are involved with...
* Mergers and Acquisitions
* Cooperative and Licensing Agreements
* Joint Ventures

Freedonia Private Companies Report #1429
Cosmeceuticals
Cosmeceuticals - Private Companies Report profiles more than 110
private U.S. producers and distributors of cosmeceutical products.
This information will assist in making decisions concerning
acquisitions, joint ventures and cooperative agreements.
Report Publication Date: May 2001
Price: $3,200
Pages: 230
Examine the report highlights, sample pages and table of contents
on the following pages and see how Cosmeceuticals - Private
Companies Report can serve as a valuable decision making tool for
your company.
Brochure Index
Table of Contents and List of Tables ............................................... 2
List of Companies Profiled .............................................................. 3
Sample Pages and Tables from:
Private Company Profiles ............................................ 4
Market Overview ......................................................... 6
Industry Structure ........................................................ 7
Report Highlights ............................................................................. 8
About the Company ......................................................................... 9
Advantages of Freedonia Reports ..................................................... 9
Our Customers .............................................................................. 10
Related Studies and Reports from Freedonia ................................. 11
Ordering Information..................................................................... 12

List of Contents,
Tables and Charts
This new report profiles more than 110 private U.S.
companies active in the cosmeceuticals industry. To
frame the industry, Freedonia analysts have prepared
an overview of the market and general industry. The
analysis explores the key indicators that drive demand,
highlights company capabilities and annual
sales, identifies private company characteristics and
shows regional concentration.
I. EXECUTIVE SUMMARY
II.
MARKET OVERVIEW
General ....................................................................................... 4
Demographics ......................................................................... 5
Demographic Trends .............................................................. 7
Cosmetics & Toiletries Outlook ............................................ 7
Table - Cosmetic & Toiletry Supply & Demand ................ 9
Dermatological Pharmaceutical Shipments ........................... 10
Table - Dermatological Pharmaceutical Shipments .......... 11
Cosmeceuticals Outlook .......................................................... 11
Products ............................................................................... 12
Cosmeceutical Products Demand ..................................... 14
Skin Care .......................................................................... 14
Chart - Skin Care Cosmeceutical Products
Demand, 2000 ............................................................ 19
Hair Care ......................................................................... 19
Chart - Hair Care Cosmeceutical Products
Demand, 2000 ............................................................ 21
Professional & Other ....................................................... 21
Chart - Professional & Other Cosmeceutical
Products Demand, 2000 ................................................. 24
Chemicals ............................................................................. 25
Table - Cosmeceutical Chemicals Demand ....................... 30
III.
INDUSTRY STRUCTURE
General ..................................................................................... 31
Table - Leading Private Cosmeceutical Companies, 2000 .... 33
Consolidation Trends & Recent Acquisitions ........................... 34
Table - Recent Private Cosmeceutical Company Acquisitions ..... 35
Cosmeceutical Products ........................................................... 35
Chart - US Cosmeceutical Products Market Share, 2000 ..... 37
Market Share ........................................................................ 36
Private Company Characteristics .......................................... 38
Skin Care Products ........................................................... 38
Table - Selected Private Cosmeceutical Skin Care
Product Companies .................................................... 41
Hair Care, Professional & Other Products ....................... 44
Table - Selected Private Hair, Professional & Other
Cosmeceutical Product Companies ............................ 47
Cosmeceutical Chemicals ......................................................... 49
Market Share ........................................................................ 49
Chart - US Cosmeceutical Chemicals Market Share, 2000 ..... 51
Private Company Characteristics .......................................... 51
Table - Selected Private Cosmeceutical
Chemical Companies ...................................................... 53
Regional Concentration ............................................................ 55
Chart - Geographic Distribution of Private Cosmeceutical
Related Establishments ....................................................... 58
IV. PRIVATE COMPANY PROFILES................................ 63-230
2
Cosmeceuticals - Private Companies Report #1429

Companies
Profiled
* Sample profiles
on pages 4 and 5
Active Organics Inc.
Agro-Mar Inc.
Alacer Corp.
Allerderm Laboratories Inc.
Aloe Pure Inc.
Aloe Up
Aloe Vera Products
Aloecorp
Alzo International Inc.
Pharmetic Mfg. Co. LLC
Ambix Laboratories Inc.
American Distilling & Mfg. Inc.
American Casein Co.
Aphrodisia Products Inc.
Arista Industries Inc.
The Austin Group
Barnet Products Corp.
Bays-Brown Laboratories
Bell Flavors & Fragrances Inc.
Beta Dermaceuticals Inc.
Bio-Botanica Inc.
BioMedic Research Laboratories Inc.
Biosil Technologies Inc.
Blistex Inc.
Browne (ET) Drug Co. Inc.
Burt’s Bees Inc.
Calmoseptine Inc.
Cargill Inc.
Carlson (JR) Laboratories Inc.
Carma Laboratories Inc.
Carrubba Inc.
Cellex-C International Inc.
Clinical Formula LLC
The Collaborative Group Ltd.
Clear Solutions Biotech Inc.
Collaborative Laboratories Inc.
Phillip Rockley Ltd.
ConSeal International Inc.
Cosmopro Inc.
Pevonia Botanica
Country Life Inc.
Desert Essence
Tea Tree Solutions
Den-Mat Corp.
DermaRite Industries LLC
Desert Whale Jojoba Co.
DPT Laboratories Ltd.
Elge Inc.
Enzymatic Therapy Inc.
exCel Cosmeceuticals
The Fanning Corp.
FANCOR
FAR Research Inc.
Ferndale Laboratories Inc.
Freeman Industries LLC
Frontier Pharmaceutical Inc.
Fruit of the Earth Inc.
Frutarom Meer Corp.
Garuda International Inc.
Genesis Pharmaceutical Inc.
Gentle Ridge
Golden Neo-Life Diamite International
Greeff (RW) & Co. LLC
Haldin International Inc.
Hall (CP) Co.
HallStar
RTD Chemicals Corp.
RTD-HallStar
Harrison Specialty Co. Inc.
Highland Laboratories Inc.
Indena USA
Inolex Chemical Co.
International Flora Technologies Ltd.
Floratech
International Shield Inc.
Z. Bigatti Labs
Jancas Jojoba Oil & Seed Co.
Jarchem Industries Inc.
JFC Technologies Inc.
Jame Fine Chemicals Inc.
Kemin Industries Inc.
Kool Down Inc.
Suntan Dan Research Laboratories
Life Services Supplements Inc.
Lipo Chemicals Inc.
Maybrook Inc.
MD Formulations
Melaleuca Inc.
Mountain Ocean Ltd.
Napp Technologies Inc.
National Vitamin Co. Inc.
Natrium Products Inc.
Nature’s Best Inc.
NeoStrata Co. Inc.
TriStrata Technology Inc.
Neways International
Northwest Cosmetic Labs
Ole Henriksen Face and Body
OMP Inc.
Obagi Medical Products
Palm Laboratories Inc.
Pedinol Pharmacal Inc.
Person & Covey Inc.
Peter Thomas Roth Labs LLC
Pharmaceutical Specialties Inc.
Physician’s Choice of Arizona Inc.
Planet Emu Inc.
Presperse Inc.
PureTek Corp.
Raining Rose Inc.
Virgin Body Care
RITA Corp.
Sabinsa Corp.
Seltzer Chemicals Inc.
Skin Formation Inc.
SkinCeuticals Inc.
Solar Cosmetic Labs Inc.
Stiefel Laboratories Inc.
Sue’s Amazing Lip Stuff Inc.
Summers Laboratories Inc.
sunSmart Inc.
NPR Healthcare
Particle Sciences Inc.
Tanning Research Laboratories
Tender Corp.
Terad International Inc.
Terry Laboratories Inc.
Therapy Systems Inc.
Topifram Laboratories Inc.
TransDermal Technologies Inc.
Tri-K Industries Inc.
Vege-Tech Co.
Vitamin Power Inc.
Vitamins Inc.
York Pharmaceuticals Inc.
Young (WF) Inc.
ZMO Co. Inc.
Freedonia Private Companies Report
Order form on last page
3

Detailed Company Profile
More than 110 private
company profiles are compiled
and range from detailed to
brief company descriptions.
(See Samples)
NeoStrata Company Incorporated
Four Research Way
Princeton, NJ 08540
County: Mercer
County Code: 34021
PRIVATE COMPANY PROFILES
All companies are individually
contacted and the
majority of the companies
verify the data.
Hard to obtain sales and
employment figures, key
products and services and
an overview of corporate
operations are provided.
Phone: 609-520-0715
Web Address: http://www.neostrata.com
Annual Sales: $
PRIVATE COMPANY PROFILES
Employment: SAMPLE PROFILE
Principal Owner(s): Ruey Yu and Eugene Van Scott
Key Executive: Richard H. Wildnauer, President
which are marketed under the AHCARE tradename.
Key Products: alpha hydroxy acid-based and other dermatologicals
Census Code SIC(s): In 2834; addition, 2844 NeoStrata also has a wholly owned subsidiary, TriStrata
Technology Incorporated, which controls many patents on AHA technology.
SIC Description(s): TriStrata pharmaceutical licenses the preparations; technology to perfumes, companies cosmetics such as L'Oreal and (France), Avon,
other toilet preparations Unilever (United Kingdom) and Beiersdorf (Germany). TriStrata also has a
nonexclusive agreement with Genesis Pharmaceutical which covers the sale of
Genesis' products that contain the AHAs glycolic and/or lactic acid.
NeoStrata manufactures dermatologicals, most of which are based on
alpha hydroxy acids Many (AHA). of NeoStrata's These products products are are sold based under on the glycolic NEOSTRATA, acid, an AHA;
NEOCEUTICALS gluconolactone, and EXUVIANCE a poly brand hydroxy names. acid The (PHA); products or NEOHYDROXY are designed complex, an
for use by dermatologists AHA blend. and These plastic products surgeons, are as designed well as to by minimize salon and signs spa of aging by
professionals, and reducing for at-home wrinkles use. and In fine addition, lines; treat the Company sun-damaged produces skin and dermatological
glycolic acid-based conditions skin peels such for as use acne; by and physicians lighten hyperpigmented during office procedures. skin. Glycolic acid is
derived from sugar cane and can easily be absorbed into the skin. Products
The Company holds containing over PHAs 80 patents are formulated on AHA technology for treatment and of hasensitive skin.
research and marketing agreements with Germany-based Henkel and Cognis
Care Chemicals (Cognis) The Company's for the development NEOSTRATA of AHA anti-aging complexes. products For are available as
example, Cognis creams, Care Chemicals' lotions and exclusive gels. For marketing example, NEOSTRATA agreement withAHA SKIN
NeoStrata includes SMOOTHING the development CREAM of has the an next eight-percent generation glycolic of AHA acid complexes, content and is
designed to treat dry, rough and sun-damaged skin on the face and neck.
© Copyright by The Freedonia Among Group, the acne Inc. treatments is NEOSTRATA AHA SOLUTION FOR OILY
SKIN. The solution contains eight percent glycolic acid, which eliminates
excess oil and sebum, and exfoliates the skin. NeoStrata's hyperpigmentation
treatments include NEOSTRATA AHA GEL for age spots and lightening. The
gel consists of two percent hydroquinone and ten percent glycolic acid in a
water base. NEOSTRATA AHA GEL can be used on age spots, freckles, solar
lentigines, and discolorations associated with pregnancy or use of oral
© Copyright by The Freedonia Group, Inc.
4
Cosmeceuticals - Private Companies Report #1429

Brief Company Profile
These profiles give you insight into the
operations of private companies, and can
help you:
• Identify companies for investment,
PRIVATE COMPANY PROFILES
merger, and/or acquisition opportunities
based on size, products,
and location.
• Evaluate the position of your
competitors based on sales and/or
employment figures.
Kemin Industries Incorporated
2100 Maury Street
Des Moines, IA 50301
County: Polk
County Code: 19153
Phone: 515-266-2111
Fax: 515-266-8254
Web Address: http://www.kemin.com
Annual Sales:
SAMPLE PROFILE
Employment:
Key Executive: Chris E. Nelson, President
Key Cosmeceutical Products: lutein
Related Census Code SIC(s): 2869
SIC Description(s): miscellaneous industrial organic chemicals
Kemin Industries is a producer of livestock feed ingredients and
preservatives, pet food ingredients, food ingredients and nutraceuticals. The
Company also operates under the Kemin Americas name. Among the products
manufactured by Kemin are organic minerals, pigmenters, preservatives,
enzymes, surfactants, mold inhibitors, palatants, antioxidants, acidifiers and
lutein. The Company has subsidiaries worldwide with manufacturing facilities
located in Texas and Iowa, as well as in Belgium, Singapore, Thailand and
India.
© Copyright by For The the Freedonia cosmeceutical Group, industry, Inc. Kemin produces lutein, which is
marketed under the FLORAGLO brand name. Lutein is a carotenoid found in
many fruits and vegetables such as spinach, kale and corn, as well as in egg
yolks. FLORAGLO, when used on the skin, acts as an antioxidant which
protects against ultraviolet A and B, and blue light radiation.
© Copyright by The Freedonia Group, Inc.
Freedonia Private Companies Report
Order form on last page
5

Market Overview
The Market Overview Section
discusses factors influencing supply
and demand, including demographic
trends and the outlook for
cosmetics and toiletries.
Cosmeceuticals Demand - Skin Care
MARKET OVERVIEW
This information helps you:
• Determine what external factors
will impact future supply and
demand
• Measure your market and sales
potential based on supply and
demand forecasts.
Demand for skin care cosmeceuticals is expected to expand seven percent per
annum to $2.6 billion in 2005. The market penetration of private label brands
and the rapid transition of innovative value-added ingredients from premiumpriced
prestige SAMPLE brands to PAGE the shelves of mass merchandisers will intensify pricing
competition and moderate value gains. Demand will be driven, however, by
affluent and health-conscious middle-aged and elderly consumers who are willing to
spend the money necessary to buy products that stave off the aging process.
Other growth stimulants include increasing concerns about the deleterious effects
of overexposure to the rays of the sun.
Skin care cosmeceuticals encompass age-defying products, medicated lotions, sun
protection products, acne preparations and other miscellaneous skin care products.
Age-defying products will continue to account for the largest share of the skin care
cosmeceutical market and will record the fastest gains through 2005. This
segment of the industry was invigorated in the early 1990s by the introduction of
active ingredients, such as alpha hydroxy acid and retinol, which produced
demonstrable results, providing both health and appearance benefits, as opposed to
the traditional moisturizing products which preceded them. Age-defying products
include lotions, exfoliants, masks, cleansers, skin lighteners and other age-defying
• Propose new areas for product
development based on market
trends & innovations.
FACTORS AFFECTING cosmeceuticals. HAIR CARE COSMECEUTICAL PRODUCTS DEMAND BY
TYPE
Product Factors
Medicated
Stimulating
lotions comprise
Demand
one of the lowest
Factors
value-added
Inhibiting
product
Demand
groups sold by
the cosmeceuticals industry, and demand is expected to be below average. These
Finasteride-Based Aggressive marketing and television Market limited to males aged 18 and
cosmeceuticals are designed to improve intrinsic skin properties such as smoothness,
moisture (Merck). retention and texture, but do not provide any direct anti-aging
Hair Growth advertising for finasteride-based older.
PROPECIA
benefits. Basic formulations are comprised Lack of ofcommodity reimbursement ingredients by such as
Large mineral untapped oil, lanolin, customer glycerin base. and petrolatum. prescription Upgraded benefit formulations plans. typically add
Ease
vitamins,
of administration
especially
and
vitamin
greater
E, or botanical
Possible
extracts
side effects
to improve
including
moisturizing and
effectiveness other intrinsic thanproperties. competing products. Many producers decreased market libido. medicated lotions as broadbased
emollients for SAMPLE the management TABLE of dermatological conditions such as sunburn,
Strong
rash
pricing
and dry
flexibility
skin.
while
Aversion of some consumers to the
PROPECIA remains under patent use of prescription drugs for vanity
protection.
purposes.
Minoxidil-Based
& Other Hair
Growth
Male desires for a full head of hair.
Preferences by some consumers for a
topical application rather than a pill such
as finasteride.
Competition from finasteride-based
products and greater pricing
pressures from generic minoxidil
brands.
Ineffectiveness in roughly one-third
of clients.
6
Cosmeceuticals - Private Companies Report #1429

Industry Structure
Gain a better understanding of your
competition and analyze your
company's position in the industry
with information about the
characteristics of leading
cosmeceuticals manufacturers
including total sales, capabilities and
regional concentration.
This information helps you:
• Evaluate diversification
opportunities based
on product lines
of other private
companies.
• Understand barriers
to entry based on
industry concentration.
Selected Private
Cosmeceutical
Skin Care Product
Companies
INDUSTRY STRUCTURE
Private Company Characteristics -
Hair Care, Professional & Other Products
Private manufacturers of hair, professional and other cosmeceutical products range
from small suppliers such as $3 million Allerderm Laboratories to large firms such
as $250 million Neways International. Private companies have limited participation,
however, in the hair SAMPLE care and professional PAGE cosmeceutical product segments.
In the hair care cosmeceutical product segment, private firms are active solely
through the production of antidandruff shampoos, as the production and sale of
hair growth products are controlled by publicly-owned finasteride- and minoxidilbased
product manufacturers, Merck and Pharmacia. In the professional segment,
private companies are only active in the manufacture of peels, after-treatment
skin products and a few, low volume miscellaneous products. Botulinum toxinbased
treatments, and collagen implants and injections are primarily offered by
public firms such as Allergan and Inamed.
Private producers of antidandruff hair care products also often offer other
cosmeceuticals, and typically design their product to treat many types of scalp
problems. For example, Beta Dermaceuticals, a company with under $1 million in
sales, manufactures a number of antidandruff shampoos as well as skin care
cosmeceuticals. Person & Covey's antidandruff shampoos control dandruff,
seborrheic dermatitis and psoriasis. The company also manufactures skin care
products and has sales of $7-10 million.
• Develop positioning
strategies based on
size of competitors.
Most private companies involved in professional cosmeceuticals offer these
products as extensions of their consumer product line. For example, $15 million
NeoStrata's dermatologicals are designed for use by dermatologists and plastic
surgeons, as well as by salon and spa professionals, and for at-home use. Among
the professional products are glycolic acid-based skin peels for use by physicians
during office procedures. Another firm, $1 million Peter Thomas Roth Labs,
manufactures SAMPLE professional CHART facial peels and masks. The company also offers
cleansers, scrubs, tonics, masks, moisturizers, vitamin C products, skin repair and
rejuvenation products, sun blocks, skin lighteners and brighteners, hair and body
care products, acne products and eye creams for at-home use.
* Sales are 2000 estimates of total corporate sales including products other than cosmeceutical skin care products.
Freedonia Private Companies Report
Order form on last page
7

Report Highlights
• Five private companies in the $3 billion US cosmeceuticals
industry have total cosmeceutical product sales of over $25
million each.
• Private companies are significant producers in niche
markets such as lipcare products, sun protection products,
whitening toothpastes, acne treatments and aloe vera
ingredients.
• Private firms are most active in the manufacture of
cosmeceutical skin care products, especially age-defying
products.
• The majority of private cosmeceutical chemical producers
supply natural extracts. Many of these producers concentrate
on a particular product type such as aloe vera or other
botanical extracts.
• Consolidation and acquisition activity in the
cosmeceuticals industry is quite modest, but is expected to
rise as demand grows, with private firms serving as primary
targets for larger public companies.
• California has the largest concentration of private
cosmeceutical and related production establishments with
over 250, followed by Florida, Illinois, New Jersey, New
York and Texas with over 100 each.
• Demand for cosmeceutical products is expected to grow
7.6 percent yearly to $4.3 billion in 2005, while demand
for cosmeceutical chemicals is projected to rise 9.2 percent
per annum to $1 billion.
8
Cosmeceuticals - Private Companies Report #1429

About
The Freedonia Group
The Freedonia Group, Inc. is a leading international industry report/
database company.
Since 1985, Freedonia has published over 1,600 titles covering areas such as
building materials, chemicals, plastics, industrial components and equipment,
household goods, coatings and adhesives, health care, packaging,
security, and many other industries.
Private companies reports encompass not only Freedonia's notable industry
forecasts, but also market shares, product information and sales and employment
figures for private companies. Corporate analysts are constantly monitoring
privately-held companies to provide the most up-to-date and comprehensive
profiles. Freedonia is able to gather and prepare this proprietary information
based on our reputation as a leading market research firm.
Advantages
of Freedonia Reports
By obtaining Freedonia's report on private companies in the
cosmeceuticals industry, you will be able to:
• Identify companies for possible investment, merger,
and /or acquisition opportunities based on size,
products and location.
• Measure your market and sales potential based on
demand forecasts.
• Propose new areas for product development based
on material trends.
• Develop positioning strategies based on size and
geographic location of competitors.
• Evaluate diversification opportunities based on product
lines of other private companies.
• Understand barriers to entry based on industry
concentration and market shares.
Freedonia Private Companies Report
Order form on last page
9

Our Customers
Freedonia's clients include major US and international companies in
the manufacturing, services, consulting and financial sectors.
Typical purchasers of Freedonia studies :
• Key Executives
• Corporate Planners
• Market Researchers
• Financial Analysts
• Information Centers
• New Product Developers
• Merger & Acquisition Specialists
Since 1985 we have provided research to customers ranging in size
from global conglomerates to one person consulting firms. More than
90% of the industrial companies in the Fortune 500 use Freedonia
research to help with their strategic planning.
Some of Freedonia's customers in the cosmeceuticals industry
include: Cargill, BASF and Bayer.
Because Freedonia is a source for reliable information, our forecasts
have been cited in numerous publications such as The Wall Street
Journal, Chemical Week and Chemical Market Reporter.
10
Cosmeceuticals - Private Companies Report #1429

Related Studies
and Reports
For more information about
these or other Freedonia titles,
please contact us at:
The Freedonia Group, Inc.
Phone: (440) 684-9600
(800) 927-5900
Fax: (440) 646-0484
Cosmeceuticals
The US market for cosmeceuticals will grow 7.6%
annually to 2005, driven by consumer demands for
more effective appearance-enhancing and age-defying
preparations. Skin care will remain the largest segment
while professional products used for facial implants,
injections, chemical peels and related procedures
grow the fastest. This study analyzes the $3 billion US
cosmeceuticals industry to 2005 and 2010 by product
and market. It also examines market drivers, details
market share and profiles key companies.
#1414. . . . . . . . . 4/01. . . . . . . . . . $3,700
Plant-Derived Chemicals
Demand for plant-derived chemicals in the US will
grow over 7% annually. Growth will be driven by new
plant-based pharmaceuticals and gains in the beverage
market, where consumers are preferring higher
natural flavor loadings. Botanical extracts will be the
fastest growing segment, surpassing essential oils as
the top product by 2010. This study analyzes the $2
billion US plant-derived chemical industry to 2005
and 2010 by product and market. It also presents
market share data and profiles key companies.
#1393. . . . . . . . . 2/01. . . . . . . . . . $3,600
Enzymes - Private Companies Report
Private and start-up firms play an active role in the $1.8
billion US specialty and industrial enzyme industry. In
1999, the top two private companies had total enzyme
sales of over $25 million. In addition, 16 other private
and start-up firms had total sales over $25 million,
including products other than enzymes. This report
profiles more than 100 privately-held US companies
(e.g., Altus Biologies, Promega). It also provides
market share data, list companies by product and
location, and forecasts industry demand.
#1353. . . . . . . . . 1/01. . . . . . . . . . $3,200
Industrial & Specialty Enzymes
Specialty and industrial enzymes demand in the US
will grow over 7% annually, spurred by the advent of
novel biocatalysts targeted at a myriad of end uses
(e.g., textiles, cosmetics). Medical and diagnostic
enzymes will remain the leading end use by value. The
enzyme industry will continue to benefit from biotechnology-based
approaches to production. This
study analyzes the $1.8 billion US enzymes industry
to 2004 and 2009 by product and market. It also
presents market share data and profiles key firms.
#1318. . . . . . . . . 9/00. . . . . . . . . . $3,500
Nutraceuticals -
Private Companies Report
Private US nutraceutical firms are significant players
in niche markets, with one controlling 5% of the
market in 1999. A total of 8 private firms had related
sales of at least $100 million, with two of these topping
$1 billion. This report profiles over 140 privately-held
US firms (e.g., Alticor, Boehringer Ingelheim, Cargill,
Global Health Sciences, Herballife, Leiner Health
Products, Pharmavite, Vitaquest). It also forecasts
industry demand, reviews recent acquisitions, and lists
firms by product and location.
#1387. . . . . . . . . 2/01. . . . . . . . . . $3,200
Pharmaceutical Chemicals
US demand for pharmaceutical chemicals will increase
7% annually. Bulk hormones and related agents
will see the fastest growth based on new bioengineered
compounds for cancer, diabetes and infertility. Respiratory
chemicals will also do well spurred by improved
asthma and allergy therapies. This study analyzes the
$14.6 billion US pharmaceutical chemicals industry
to 2004 and 2009 by therapeutic class, regulatory
status, and production source. It also presents market
share data and profiles key industry players.
#1311. . . . . . . . . 8/00. . . . . . . . . . $3,800
Nutraceuticals
US demand for nutraceuticals will grow nearly 7%
annually. Herbal and related extracts will grow the
fastest based on expanding scientific evidence of health
benefits and the rising popularity of alternative medicines.
Nutrients and functional additives will also
generate strong sales gains, spurred by ongoing advances
in the quality of ingredients. This study examines
the $1.9 billion US nutraceuticals industry to
2004 and 2009 by type and end-use. It also evaluates
market share and profiles key firms.
#1359. . . . . . . . . 11/00. . . . . . . . . . $3,700
World Nutraceuticals
World demand for nutraceuticals will grow over 10%
per year. Functional food additives will grow the
fastest spurred by new products, broadening end-use
applications, greater pricing flexibility and increasing
number of health conscious consumers. Global demand
for herbal extracts will also advance at a strong
pace. This study analyzes the $6.8 billion world
nutraceutical industry to 2004 and 2009 by product
in six regions and 12 individual countries. It also
details market share and profiles key producers.
#1289. . . . . . . . . 6/00. . . . . . . . . . $4,600
Freedonia Private Companies Report
Order form on last page
11

How to Order
For more information about our products,
please call the Freedonia Customer Service
Department at (440) 684-9600 or
(800) 927-5900 or fax (440) 646-0484.
Ordering Information
Fill out the coupon below and mail it to The Freedonia Group, or
send your order by fax (440) 646-0484, or E-mail to
info@freedoniagroup.com
Handling and Shipping is FREE
There is NO charge for handling and shipping. In the US we ship via
UPS. Outside the US, we provide free airmail service. If you would
like express delivery, we provide this to you at cost.
Save Fifteen Percent
If you order three (3) different titles at the same time, you can receive a
discount of 15 percent. If your order is accompanied by a check, you may
take a 5 percent cash discount (discounts do not apply to corporate use
licenses).
Use Credit Card
You may charge your order to either Visa, MasterCard or American
Express. Please include your credit card account number, expiration
date and your signature.
Corporate Use Licenses
Now every decision maker in your organization
can act on the key intelligence found in
all Freedonia studies. For an additional
$2,000, you receive unlimited use of an electronic
version (PDF) of the study. Place it on
your Intranet, e-mail it to coworkers around
the world, or print it as many times as you
like! Order it today.
Orders Outside of the US
Checks must be paid in US funds and drawn against a US bank. Wire
transfers should be sent to: Fifth Third Bank, Cincinnati, Ohio; The
Freedonia Group, Inc.; SWIFT #FTBCUS3C; ABA #042000314;
Account #830-51814 (please include study number and/or invoice
number with all wire transfers).
Additional Copies
Additional copies are available to original purchasers at $400 per title.
Online Access
The complete text and tables from our studies and reports can be found
on our Web site www.freedoniagroup.com and through major commercial
online vendors.
THE FREEDONIA GROUP, INC.
767 Beta Drive
Cleveland, OH 44143-2326 USA
Phone: (440) 684-9600 • (800) 927-5900
Fax: (440) 646-0484
Name:
Title:
TITLE
PRICE
#1429 Cosmeceuticals - Private Companies Report $3,200
Corporate Use License (add to study price) + $2,000
Additional Print Copies @ $400 Each
Company:
Division:
Street:
(no PO Box please)
City/State/Zip:
Please check method of payment:
Total: $
Enclosed is my check (5% discount) drawn on a US bank and payable to The
Freedonia Group, Inc., in US funds. (Ohio residents add 7% sales tax).
Bill my company MasterCard Visa American Express
Country:
Phone:
Fax:
MO.
YR.
Email:
SHIPPING and HANDLING charges are FREE via UPS
(USA only) or airmail (Outside USA). Express delivery
available at cost. Please inquire.
Credit Card #
Signature:
Expiration Date